Therapeutic Efficacy of a Coriolus versicolor-Based Vaginal Gel in Women with Cervical Uterine High-Risk HPV Infection: A Retrospective Observational Study.
Colposcopy
Coriolus versicolor
Cytology
HPV-DNA
Human papillomavirus
Vaginal gel
Journal
Advances in therapy
ISSN: 1865-8652
Titre abrégé: Adv Ther
Pays: United States
ID NLM: 8611864
Informations de publication
Date de publication:
02 2021
02 2021
Historique:
received:
28
09
2020
accepted:
04
12
2020
pubmed:
29
12
2020
medline:
15
4
2021
entrez:
28
12
2020
Statut:
ppublish
Résumé
A Coriolus versicolor-based vaginal gel is available for treating women with cervical uterine high-risk human papillomavirus (HPV) infection through re-epithelizing and re-balancing microbiota actions. A longitudinal retrospective observational study was performed to evaluate efficacy and safety of the gel. Women treated with Coriolus versicolor-based vaginal gel were compared with women not treated with the gel. Both groups were monitored for HPV infection by an HPV DNA test, Pap smear (cytology) and colposcopy at baseline and after 6 months. Overall, 183 high-risk HPV positive women were enrolled (97 treated and 86 controls). After 6 months, the HPV DNA test became negative in 67.0% versus 37.2% of treated and controls, respectively (p < 0.0001). Furthermore, 76.1% versus 40.8% registered a colposcopy improvement (p = 0.0005) and 60.4% versus 40.8% showed a remission (p = 0.05), for treated versus controls, respectively. Regarding to cytology, 78.5% of treated versus 37.7% of controls registered an improvement, while 70.8% of treated versus 34.8% of controls had a remission (p < 0.0001 for both variables). At multivariate analyses adjusted for age, smoking habit, and use of estroprogestinic pill, compared to controls, women treated with the gel showed a significantly higher likelihood to experience the clearence of HPV DNA (OR 4.81; 95% 2.43-9.53), and remission at colposcopy (OR 2.30; 95% 1.00-5.31), and cytology (OR 5.13; 95% 2.40-10.96) at 6 months. No adverse event was reported during the follow-up. The use of a Coriolus versicolor-based vaginal gel in high-risk HPV patients is safe and effective based on all examined tests.
Identifiants
pubmed: 33367986
doi: 10.1007/s12325-020-01594-6
pii: 10.1007/s12325-020-01594-6
doi:
Substances chimiques
DNA, Viral
0
Vaginal Creams, Foams, and Jellies
0
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Pagination
1202-1211Références
McQuillan G, Kruszon-Moran D, Markowitz LE, Unger ER, Paulose-Ram R. Prevalence of HPV in Adults Aged 18–69: United States, 2011–2014. NCHS Data Brief. 2017;280:1–8.
Satterwhite CL, Torrone E, Meites E, et al. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis. 2013;40:187–93.
doi: 10.1097/OLQ.0b013e318286bb53
Viens LJ, Henley SJ, Watson M, et al. Human papillomavirus-associated cancers—United States, 2008–2012. Morb Mortal Wkly Rep. 2016;65:661–6.
doi: 10.15585/mmwr.mm6526a1
Gillison ML, Broutian T, Pickard RK, et al. Prevalence of oral HPV infection in the United States, 2009–2010. JAMA. 2012;307:693–703.
doi: 10.1001/jama.2012.101
Giorgi Rossi P, Chini F, Borgia P, et al. Gruppo di lavoro HPV Prevalenza [Human Papilloma Virus (HPV), cervical cancer incidence and screening uptake: differences among Northern, Central and Southern Italy]. Epidemiol Prev. 2012;36:108–19.
pubmed: 22706361
Ault KA. Epidemiology and natural history of human papillomavirus infections in the female genital tract. Infect Dis Obstet Gynecol. 2006 Suppl:40470.
https://www.who.int/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cancer . Accessed 11 Nov 2020.
Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118:3030–44.
doi: 10.1002/ijc.21731
Grce M, Mravak-Stipetić M. Human papillomavirus–associated diseases. Clin Dermatol. 2014;32:253–8.
doi: 10.1016/j.clindermatol.2013.10.006
World Health Organization. Comprehensive cervical cancer control. A guide for essential practice, second edition. https://www.who.int/reproductivehealth/publications/cancers/cervical-cancer-guide/en/ . Accessed 11 Nov 2020.
SICPCV: Gestione della paziente conPap-test anormale. Linee Guida Edizione2006. Anno XXI;N.1 Dicembre 2006 [Italian]
Castellsagué X. Natural history and epidemiology of HPV infection and cervical cancer. Gynecol Oncol. 2008;110:S4-7.
doi: 10.1016/j.ygyno.2008.07.045
Trimble CL, Peng S, Thoburn C, Kos F, Wu TC. Naturally occurring systemic immune responses to HPV antigens do not predict regression of CIN2/3. Cancer Immunol Immunother. 2010;59:799–803.
doi: 10.1007/s00262-009-0806-4
Trimble CL, Clark RA, Thoburn C, et al. Human papillomavirus 16-associated cervical intraepithelial neoplasia in humans excludes CD8 T cells from dysplastic epithelium. J Immunol. 2010;185:7107–14.
doi: 10.4049/jimmunol.1002756
Couto S. Evaluation of Coriolus versicolor supplementation in HPV patients. Clin J Mycol. 2007;2:2–5.
Shukla S, Bharti AC, Hussain S, et al. Elimination of high-risk human papillomavirus type HPV16 infection by “Praneem” polyherbal tablet in women with early cervical intraepithelial lesions. J Cancer Res Clin Oncol. 2009;135:1701–9.
doi: 10.1007/s00432-009-0617-1
Scardamaglia P, Carraro C, Mancino P. Stentella P [Effectiveness of the Treatment With Beta-Glucan in the HPV-CIN 1 Lesions]. Minerva Ginecol. 2010;62:389–94.
pubmed: 20938424
Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002;287:2114–9.
doi: 10.1001/jama.287.16.2114
Marcuccilli F, Farchi F, Mirandola W, et al. Performance evaluation of AnyplexTMII HPV28 detection kit in a routine diagnostic setting: comparison with the HPV Sign® Genotyping Test. J Virol Methods. 2015;217:8–13.
doi: 10.1016/j.jviromet.2015.02.018
Palacios S, Losa F, Dexeus D, Cortés J. Beneficial effects of a Coriolus versicolor-based vaginal gel on cervical epithelization, vaginal microbiota and vaginal health: a pilot study in asymptomatic women. BMC Womens Health. 2017;17:21.
doi: 10.1186/s12905-017-0374-2
Gajino Suárez C. Use and results of a Coriolus versicolor-based vaginal gel in women HPV+ and/or abnormal pap smear attended in a regional Spanish hospital. Preliminary analysis. In: Eurogin Congress 2018, Lisbon, Portugal, December 2–5, 2018, Abstract no. 00097.
Marín Ortiz E, Vázquez Caamaño MP, et al. Efficacy of a Coriolus versicolor-based vaginal gel in high-risk HPV+ women. Preliminary results. In: Eurogin Congress 2018, Lisbon, Portugal, December 2–5, 2018, Abstract no. 00098.
Riera M, Rupérez B, Lázaro I, et al. Effect of a multi-ingredient vaginal gel on clearance and/or cytology normalization in high-risk HPV positive patients. [Abstract]. J Low Genit Tract Dis. 2020;24(1S):S16.
Serrano L,López AC, Gónzalez S, et al. Effect of a coriolus versicolor-based vaginal gel in HPV infected women: normalizing HPV-dependent cervical lesions (ascus/lsil) and high-risk HPV clearance. In: Eurogin Congress 2019, Monaco December 4–7, 2019, Abstract no. #0280
Serrano L, López AC, González S, Palacios S, Dexeus D, Centeno C, et al. Effect of a Coriolus versicolor-based vaginal gel in HPV infected women: cervical reepithelization, perceived stress and tolerability evaluation. In: Eurogin Congress 2019, Monaco December 4–7, 2019, Abstract no. #0405
Emsellem C, Cortés J, de Santiago J, et al. Efficacy of a multi-ingredient vaginal gel in repairing HPV-dependent cervical lesions in real-life: interim analysis. [Abstract]. J Low Genit Tract Dis. 2020;24(1S):S16–7.
Gaslain Y, Cortés J, Dexeus D, et al. Effect of a multi-ingredient vaginal gel in high-risk HPV infected patients: results of different studies [Abstract]. J Low Genit Tract Dis. 2020;24(1S):S15–6.
Rajera R, Nagpal K, Singh SK, et al. Niosomes: a con-trolled and novel drug delivery system. Biol Pharm Bull. 2011;34(7):945–53.
doi: 10.1248/bpb.34.945
Chu KK, Ho SS, Chow AH. Coriolus versicolor: a medicinal mushroom with promising immunotherapeutic values. J Clin Pharmacol. 2002;42(9):976–84.
doi: 10.1177/009127002401102894
Cui J, Chisti Y. Polysaccharopeptides of Coriolus versicolor: physiological activity, uses, and production. Biotechnol Adv. 2003;21(2):109–22. https://doi.org/10.1016/s0734-9750(03)00002-8 .
doi: 10.1016/s0734-9750(03)00002-8
pubmed: 14499133
Shukla S, Bharti AC, Hussain S, Mahata S, Hedau S, Kailash U, Kashyap V, Bhambhani S, Roy M, Batra S, Talwar GP, Das BC. Elimination of high-risk human papillomavirus type HPV16 infection by “Praneem” polyherbal tablet in women with early cervical intraepithelial lesions. J Cancer Res Clin Oncol. 2009;135(12):1701–9.
doi: 10.1007/s00432-009-0617-1
Bylka W, Znajdek-Awiżeń P, Studzińska-Sroka E, Dańczak-Pazdrowska A, Brzezińska M. Centella asiatica in dermatology: an overview . Phytother Res. 2014;28(8):1117–24.
doi: 10.1002/ptr.5110
Chen J, Geng L, Song X, Li H, Giordan N, Liao Q. Evaluation of the efficacy and safety of hyaluronic acid vaginal gel to ease vaginal dryness: a multicenter, randomized, controlled, open-label, parallel-group, clinical trial. J Sex Med. 2013;10(6):1575–84.
doi: 10.1111/jsm.12125
Radha MH, Laxmipriya NP. Evaluation of biological properties and clinical effectiveness of Aloe vera: A systematic review. J Tradit Complement Med. 2014;5(1):21–6.
doi: 10.1016/j.jtcme.2014.10.006
Shedoeva A, Leavesley D, Upton Z, Fan C. Wound healing and the use of medicinal plants. Evid Based Complement Altern Med. 2019;22(2019):2684108.
Gao W, Weng J, Gao Y, et al. Comparison of the vaginal microbiota diversity of women with and without human papillomavirus infection: a cross-sectional study. BMC Infect Dis. 2013;13:271.
doi: 10.1186/1471-2334-13-271